Blood biomarkers of Alzheimer’s disease, including p-tau217, are linked with faster progression from mild cognitive impairment to dementia, supporting their potential for risk stratification at the stage of mild cognitive impairment in the community.
- Martina Valletta
- Davide Liborio Vetrano
- Giulia Grande
